
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About
EUDA Health Holdings Limited (EUDA)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: EUDA (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $6
1 Year Target Price $6
1 | Strong Buy |
0 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -23.74% | Avg. Invested days 32 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 42.36M USD | Price to earnings Ratio - | 1Y Target Price 6 |
Price to earnings Ratio - | 1Y Target Price 6 | ||
Volume (30-day avg) 1 | Beta -0.1 | 52 Weeks Range 1.03 - 6.30 | Updated Date 09/13/2025 |
52 Weeks Range 1.03 - 6.30 | Updated Date 09/13/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.54 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -47.08% |
Management Effectiveness
Return on Assets (TTM) -107.19% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 43393467 | Price to Sales(TTM) 10.56 |
Enterprise Value 43393467 | Price to Sales(TTM) 10.56 | ||
Enterprise Value to Revenue 10.82 | Enterprise Value to EBITDA -25.9 | Shares Outstanding 37156400 | Shares Floating 18401534 |
Shares Outstanding 37156400 | Shares Floating 18401534 | ||
Percent Insiders 50.47 | Percent Institutions 2.27 |
Upturn AI SWOT
EUDA Health Holdings Limited
Company Overview
History and Background
EUDA Health Holdings Limited is a telemedicine and precision medicine company, though specific founding details and milestones are difficult to obtain through public sources.
Core Business Areas
- Telemedicine: Provides virtual healthcare consultations and remote patient monitoring services.
- Precision Medicine: Offers personalized treatment plans based on individual genetic and health data.
- Pharmacy Services: Provides digital pharmacy solutions for easy medicine procurement
Leadership and Structure
Due to limited public information, the exact leadership team and organizational structure are not readily available.
Top Products and Market Share
Key Offerings
- Telemedicine Platform: Offers virtual doctor consultations and remote monitoring. Market share data is not publicly available. Competitors include Teladoc Health (TDOC) and Amwell (AMWL).
- Precision Medicine Services: Provides genetic testing and personalized treatment plans. Market share data is not publicly available. Competitors include Exact Sciences (EXAS) and Guardant Health (GH).
Market Dynamics
Industry Overview
The telemedicine and precision medicine markets are experiencing significant growth due to increasing demand for convenient and personalized healthcare solutions.
Positioning
EUDA Health Holdings Limited aims to position itself as a provider of integrated telemedicine and precision medicine solutions. Competitive advantages include its technology platform and focus on personalized care.
Total Addressable Market (TAM)
The combined TAM for telemedicine and precision medicine is estimated to be in the hundreds of billions of dollars. EUDA Health's positioning is currently unclear relative to this vast TAM given limited public data.
Upturn SWOT Analysis
Strengths
- Integrated telemedicine and precision medicine approach
- Focus on personalized healthcare
- Technology platform
Weaknesses
- Limited brand recognition
- Small market share
- Limited financial resources
Opportunities
- Expanding telehealth adoption
- Growing demand for personalized medicine
- Partnerships with healthcare providers
Threats
- Competition from established players
- Regulatory changes
- Data privacy concerns
Competitors and Market Share
Key Competitors
- TDOC
- AMWL
- EXAS
- GH
Competitive Landscape
EUDA Health Holdings Limited faces strong competition from established players in the telemedicine and precision medicine markets. It will need to differentiate itself through its technology, services, and customer focus.
Growth Trajectory and Initiatives
Historical Growth: Historical Growth data is not available due to limited information.
Future Projections: Future Projections are not available due to a lack of analyst coverage.
Recent Initiatives: Recent Initiatives are not publicly known.
Summary
EUDA Health Holdings Limited is a relatively small player in the telemedicine and precision medicine markets. The company aims to integrate telemedicine and precision medicine. However, it will need to overcome significant challenges, including competition from established players, limited financial resources, and brand recognition issues to achieve long-term success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Market Reports
- Limited Public Information
Disclaimers:
The information provided is based on limited publicly available data and may not be entirely accurate. This is not financial advice. Please consult a financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About EUDA Health Holdings Limited
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-12-14 | CEO & Executive Director Mr. Alfred Lim | ||
Sector Real Estate | Industry Real Estate Services | Full time employees 117 | Website https://www.euda.com |
Full time employees 117 | Website https://www.euda.com |
EUDA Health Holdings Limited operates as a non-invasive healthcare provider in Asia. The company operates in two segments, Property Management Services; and Holistic Wellness Consumer Products and Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company also provides property management services in shopping malls, business office building, and residential apartments to various tenants and property owners. In addition, it offers holistic wellness consumer products and services, such as wellness therapies, licensing services of bioenergy cabins, and wellness membership program services. The company is headquartered in Singapore.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.